Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Completion pneumonectomy. Indications and results].

W Jungraithmayr1, J Hasse, M Olschewski

  • 1Abteilung für Thoraxchirurgie, Universitätsklinik Freiburg. jungrait@chir.ukl.uni-freiburg.de

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|July 20, 2004
PubMed
Summary

Completion pneumonectomy (CP) is a high-risk procedure but offers a cure for some. Despite high overall 30-day mortality (20.2%), long-term survival rates justify its use in select cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Search for heavy resonances that decay into a vector boson and a Higgs boson in hadronic final states at <math> </math> <math></math>.

The European physical journal. C, Particles and fields·2020
Same author

Search for physics beyond the standard model in events with two leptons of same sign, missing transverse momentum, and jets in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2020
Same author

Search for new phenomena with the <math></math> variable in the all-hadronic final state produced in proton-proton collisions at <math> </math> <math></math>.

The European physical journal. C, Particles and fields·2020
Same author

Measurement of the triple-differential dijet cross section in proton-proton collisions at <math> </math> and constraints on parton distribution functions.

The European physical journal. C, Particles and fields·2020

Area of Science:

  • Thoracic Surgery
  • Surgical Oncology
  • Critical Care Medicine

Background:

  • Completion pneumonectomy (CP) is a complex procedure with known high morbidity and mortality.
  • It is often considered the only curative option for specific patient cohorts.

Purpose of the Study:

  • To investigate the outcomes of completion pneumonectomy in patients with benign disease, malignant recurrence, or post-resection complications.
  • To identify risk factors associated with increased mortality after CP.

Main Methods:

  • Retrospective analysis of 86 completion pneumonectomy cases.
  • Categorization into three groups: benign disease, malignant recurrence, and post-resection complications.
  • Analysis of 30-day and 5-year survival rates, stratified by indication, side of surgery, and specific complications.

Related Experiment Videos

Main Results:

  • Overall 30-day mortality was 20.2%, with significant variations based on indication (0% for benign, 10% for malignant, 33.3% for complications).
  • Right-sided CP and emergency indications were associated with significantly higher 30-day mortality.
  • Patients with anastomotic or stump insufficiency had a 41% 30-day mortality rate.
  • Five-year survival was 26% for malignant disease and 32% for complications.

Conclusions:

  • Completion pneumonectomy carries a substantial risk of mortality, particularly in emergency situations and following complications.
  • Despite the risks, CP can achieve long-term survival, justifying its application in carefully selected patients.
  • Surgical strategy and patient selection are critical to optimizing outcomes after completion pneumonectomy.